Helixmith Employee Directory
Biotechnology ResearchSeoul, South Korea11-50 Employees
Helixmith is a biotechnology research company based in Seoul, South Korea, focused on developing novel biopharmaceuticals and advancing gene therapy approaches for diseases with unmet medical needs. Its pipeline includes programs in CAR-T therapies for solid tumors and an AAV vector program aimed at neuromuscular conditions, along with Engensis (VM202), a plasmid DNA therapy evaluated for diabetic peripheral neuropathy, diabetic foot ulcers, claudication, amyotrophic lateral sclerosis, coronary artery disease, and Charcot–Marie–Tooth disease. Development activities are conducted from its base in Seoul, with clinical work supported by an operation in San Diego, California. The organization positions itself within the biotechnology research sector by pursuing innovative therapies that target previously untreated diseases, and operates with a mid-sized team in the industry. The company is listed on KOSDAQ, reflecting its integrated role in the regional biopharmaceutical landscape.